期刊文献+

1,25-(OH)_2D_3对糖尿病大鼠肾脏Nephrin蛋白表达的影响 被引量:3

Effect of 1,25-(OH)_2D_3 on the Expression of Nephrin in Diabetic Rat
下载PDF
导出
摘要 目的探讨1,25-(OH)2D3对糖尿病(DM)大鼠肾脏Nephrin蛋白表达的影响。方法Wistar大鼠分为对照组、DM组、1,25-(OH)2D3组。建立糖尿病大鼠模型,实验12周末观察各组血尿、蛋白尿、肾组织光镜电镜、免疫组织化学,采用反转录聚合酶链反应(RT-PCR)检测其肾皮质NephrinmRNA及蛋白的表达。结果与对照组及1,25-(OH)2D3组相比,DM组大鼠尿红细胞及尿蛋白排泄明显增多,肾小球细胞数亦增加(P<0.01,0.05),NephrinmRNA及蛋白质表达明显下调(Pa<0.01)。1,25-(OH)2D3组肾小球细胞数、NephrinmRNA及蛋白质表达与对照组相比无统计学差异(Pa>0.05)。结论1,25-(OH)2D3可减轻血尿、蛋白尿,上调NephrinmRNA及蛋白质的表达而有肾保护作用。 Objective To explore the effect of 1,25 - ( OH)2 D3 on Nephrin protein expression in renal of diabetic rats. Methods Diabetic rats were induced by streptozotocin(STZ). Groups were divided as follows:diabetic group( DM group) , 1,25 - (OH)2D3 treated group [ 1,25 - (OH)2D3 group ] and control group. At the 12th week,haematuria and protein uria were determined and the kidneys were removed by histopathology ,immunostaining, and the expression of Nephrin mRNA and protein in renal cortex were detected by reversed transcription - polymerase chain reaction (RT- PCR). Results Compared with control and 1,25 - (OH)2D3 groups,urine erythrocyte and protein excretion and glomerlar cellulanty in DM group statistically increased( P 〈0.01,0.05 ) ,however the Nephrin mRNA and protein expression in DM group was significantly down -regulated( Pa 〈 0.01 ). Glomerular cellularity and Nephrin mRNA and protein expression in 1,25 - (OH)2 D3 group were not significant difference compared with those of control group ( Pa 〉 0.05 ). Conclusion The effect of 1,25 - ( OH ) 2 D3 is in relieving haematuria and proteinuria and up - regulate the expression of nephrin mRNA and protein to protein kidney.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2007年第20期1542-1543,1569,共3页 Journal of Applied Clinical Pediatrics
关键词 糖尿病 1 25-(OH)2D3 Nephrin蛋白 diabete 1,25 - (OH) a D3 Nephrin protein
  • 相关文献

参考文献13

  • 1Gerke P,Sellin L,Kretz O,et al.NEPH2 is located at the glomerular slit diaphragm,interacts with nephrin and is cleaved from podocytes by metalloproteinases[J].J Am Soc Nephrol,2005,16(6):1693-1702. 被引量:1
  • 2王文姬,陈楠.活性维生素D_3与肾脏病[J].肾脏病与透析肾移植杂志,2006,15(3):262-265. 被引量:12
  • 3Kuhlmann A,Haas CS,Gross ML,et al.1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat[J].Am J Physiol Renal Physiol,2004,286(3):526-533. 被引量:1
  • 4王晓青,李竞,王鹏虎.氯沙坦联合苯那普利对早期糖尿病肾病患者血清TGF-β_1及MCP-1的影响[J].新乡医学院学报,2006,23(5):517-518. 被引量:9
  • 5房启麟,李秀丽.细胞因子和粘附分子与糖尿病肾病[J].新乡医学院学报,2006,23(2):213-215. 被引量:13
  • 6Ichinose K,Maeshima Y,Yamamoto Y,et al.Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model[J].Diabetes,2005,54(10):2891-2903. 被引量:1
  • 7Bloomgarden ZT.Diabetic nephropathy[J].Diabetes Care,2005,28(3):745-751. 被引量:1
  • 8Wolf G,Chen S,Ziyadeh FN.From the periphery of the glomerular capillary wall toward the center of disease:Podocyte injury comes of age in diabetic nephropathy[J].Diabetes,2005,54(6):1626-1634. 被引量:1
  • 9Tian J,Liu Y,Williams LA,et al.Potential role of active vitamin D in retarding the progression of chronic kidney disease[J].Nephrol Dial Transplant,2007,22(2):321-328. 被引量:1
  • 10Kojiro M,Mitsuyoshi T,Michinori H,et al.A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis[J].Am J Pathol,2001,158(5):1733-1741. 被引量:1

二级参考文献50

  • 1曹宏,刘超,杨涛,刘翠萍,郭妍,覃又文.科素亚治疗糖尿病肾病的机制探讨与临床意义[J].中华糖尿病杂志(1006-6187),2004,12(4):269-270. 被引量:20
  • 2陈淑娇,郑京.ACEI、ARB阻止糖尿病肾病发展的机制[J].现代实用医学,2004,16(12):740-742. 被引量:16
  • 3钱玉润,胡春,周令芳.糖尿病肾病血TNF-α浓度的探讨[J].上海第二医科大学学报,2005,25(2):206-207. 被引量:7
  • 4Sharma BK,Ziiyadeh FN.Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy[ J ].Seminars in Nephrology,1997,17:80. 被引量:1
  • 5Sharma K,Ziyadeh FN.Hyperglycemia and diabetic kidney disease.The case for transforming growth factor beta as a key mediator[J].Diabetes,1995,44(10):1139-1146. 被引量:1
  • 6Ziyadeh FN,Han DC.Involvement of transforming growth factor-beta and its teceptors in the pathogenesis of diabetic nephrology [J].Kidney Int,1997,60 (Suppl.):S7-S11. 被引量:1
  • 7Ishii H,Tada H,Isogai S.An aldose reductase inhibitor prevents glucose-induced increase in transforming growth factor-beta and prote in kinage C activity in cultured mesangial cells [ J ].Diabetologia,1998,41 (3):362-364. 被引量:1
  • 8Cohen MP,Sharma K,Guo J,et al.The renal TGF-beta system in the db/db mouse model of diabetic nephropathy [ J ].Exp Nephrol,1998,6 (3):226-233. 被引量:1
  • 9Baud L,Fouqueray B,Philippe C,et al.Tumor necrosis factor alpha and mesangial cells[J].Kidney Int,1992,41(3):600-603. 被引量:1
  • 10Hasegawa G,Nakano K,Sawada M,et al.Possible role of necrosis factor and interleukin-1 in the development of diabetic nephropathy[J].Kidney Int,1991,40(6):1007-1012. 被引量:1

共引文献31

同被引文献106

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部